Unicycive Therapeutics In... (UNCY)
NASDAQ: UNCY
· Real-Time Price · USD
4.71
0.08 (1.73%)
At close: Aug 15, 2025, 3:59 PM
4.72
0.32%
After-hours: Aug 15, 2025, 07:57 PM EDT
Unicycive Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 19.77M | 26.14M | 32.35M | 41.78M | 48.93M | 9.7M | 14.35M | 18.82M | 24.33M | 455K | 7.01M | 10.57M | 13.62M | 16.58M | 18.01M | 1K | 147K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -953K | -1.02M | -174K | -215K | -256K | n/a | n/a | n/a | 864K | 272K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.37M | 939K | 687K | 594K | 503K | 325K | 682K | 320K | 319K | 159K | 69K | 104K | 137K | 126K | 1.71M | 864K | 272K |
Total Current Assets | 27.35M | 30.95M | 37.74M | 44.05M | 51.68M | 13.4M | 18.57M | 21.93M | 26.18M | 2.64M | 9.96M | 12.56M | 15.46M | 18.41M | 19.78M | 913K | 513K |
Property-Plant & Equipment | 601K | 720K | 833K | 647K | 709K | 792K | 873K | 953K | 1.02M | 174K | 215K | 256K | 296K | 333K | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 601K | 720K | 833K | 647K | 709K | 792K | 873K | 953K | 1.02M | 174K | 215K | 256K | 296K | 333K | n/a | 864K | 272K |
Total Assets | 27.95M | 31.67M | 38.57M | 44.7M | 52.38M | 14.19M | 19.44M | 22.88M | 27.2M | 2.82M | 10.18M | 12.82M | 15.76M | 18.74M | 19.78M | 913K | 513K |
Account Payables | 1.25M | 966K | 548K | 1.47M | 1.24M | 821K | 990K | 446K | 610K | 892K | 2.22M | 747K | 589K | 742K | 49K | 357K | 160K |
Deferred Revenue | n/a | n/a | n/a | -360K | 208K | n/a | 2.53M | 1.69M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 146K | 92K | 542K | 360K | n/a | 18K | n/a | 303K | 276K | n/a | 165K | 48K | 27K | 29K | 103K | 4.12M | 3.48M |
Other Current Liabilities | 10.59M | 18.94M | 9.37M | 7.77M | 25.15M | 13.12M | 11.53M | 12.68M | 13.11M | n/a | -89K | -48K | -27K | -29K | n/a | -23K | n/a |
Total Current Liabilities | 16.68M | 24.12M | 10.46M | 13.09M | 30.28M | 17.53M | 15.46M | 15.42M | 15.97M | 3.28M | 5.52M | 2.83M | 2.4M | 2.1M | 785K | 5.12M | 3.92M |
Long-Term Debt | n/a | n/a | n/a | n/a | 46.19M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | 117K | 265K | 274K | 46.56M | 466K | 552K | 634K | 715K | 1.05M | 29K | 72K | 114K | 155K | n/a | n/a | n/a |
Total Liabilities | 16.68M | 24.24M | 10.72M | 13.36M | 76.84M | 18M | 16.01M | 16.05M | 16.68M | 3.28M | 5.55M | 2.91M | 2.52M | 2.26M | 785K | 5.12M | 3.92M |
Total Debt | 694K | 773K | 807K | 634K | 46.9M | 811K | 866K | 937K | 991K | 201K | 194K | 280K | 296K | 335K | 109K | 4.12M | 3.48M |
Common Stock | 120K | 114K | 98K | 43K | 37K | 35K | 35K | 15K | 15K | 15K | 15K | 15K | 15K | 15K | 15K | 9K | 9K |
Retained Earnings | -100.7M | -101.27M | -79.75M | -75.65M | -85.5M | -64.54M | -56.74M | -52.41M | -48.57M | -34M | -28.67M | -23.11M | -19.48M | -15.94M | -13.19M | -7.99M | -6.89M |
Comprehensive Income | n/a | n/a | n/a | n/a | -46.22M | n/a | -44K | -26.2M | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | -0.00 | n/a |
Shareholders Equity | 11.27M | 7.43M | 27.85M | 31.34M | -24.46M | -3.81M | 3.43M | 6.83M | 10.52M | -466K | 4.63M | 9.91M | 13.24M | 16.48M | 19M | -4.2M | -3.4M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |